T
Thomas F. Lüscher
Researcher at University of Zurich
Publications - 1613
Citations - 88517
Thomas F. Lüscher is an academic researcher from University of Zurich. The author has contributed to research in topics: Endothelium & Myocardial infarction. The author has an hindex of 134, co-authored 1560 publications receiving 79034 citations. Previous affiliations of Thomas F. Lüscher include University of Texas Southwestern Medical Center & Durham University.
Papers
More filters
Journal ArticleDOI
2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA).
Steen Dalby Kristensen,Juhani Knuuti,Antti Saraste,Stefan D. Anker,Hans Erik Bøtker,Stefan De Hert,Ian Ford,José Ramón González-Juanatey,Bulent Gorenek,Guy R. Heyndrickx,Andreas Hoeft,Kurt Huber,Bernard Iung,Keld Kjeldsen,Dan Longrois,Thomas F. Lüscher,Luc Pierard,Stuart J. Pocock,Susanna Price,Marco Roffi,Per Anton Sirnes,Miguel Sousa-Uva,Vasilis Voudris,Christian Funck-Brentano +23 more
TL;DR: Clinicians will find the recommendations in these revised CPGs useful in their daily work and can be reassured that the recommendations have been vetted thoroughly by the most rigorous scientific process, so that cardiovascular clinicians worldwide may deliver optimal, standardized care.
Journal ArticleDOI
Angiotensin-Converting Enzyme Inhibition With Quinapril Improves Endothelial Vasomotor Dysfunction in Patients With Coronary Artery Disease The TREND (Trial on Reversing ENdothelial Dysfunction) Study
G. B. J. Mancini,G. C. Henry,C. Macaya,Blair J. O'Neill,A. L. Pucillo,R. G. Carere,Thomas J. Wargovich,Harald Mudra,Thomas F. Lüscher,M. I. Klibaner,H. E. Haber,A. C. G. Uprichard,Carl J. Pepine,Bertram Pitt +13 more
TL;DR: TREND (Trial on Reversing ENdothelial Dysfunction) investigated whether quinapril might improve endothelial dysfunction in normotensive patients with coronary artery disease and no heart failure, cardiomyopathy, or major lipid abnormalities so that confounding variables that affect endothelium dysfunction could be minimized.
Journal ArticleDOI
The Assessment of Endothelial Function From Research Into Clinical Practice
Andreas J. Flammer,Todd J. Anderson,David S. Celermajer,Mark A. Creager,Mark A. Creager,John E. Deanfield,Peter Ganz,Naomi M. Hamburg,Thomas F. Lüscher,Michael Shechter,Stefano Taddei,Joseph A. Vita,Amir Lerman +12 more
TL;DR: The assessment of its vasodilator properties resulting from NO and other molecules may provide information on the integrity and function of the endothelium, and most, if not all, cardiovascular risk factors are associated with endothelial dysfunction, and risk factor modification leads to improvement in vascular function.
Journal ArticleDOI
International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology
Jelena-Rima Ghadri,Ilan S. Wittstein,Abhiram Prasad,Scott W. Sharkey,Keigo Dote,Yoshihiro J. Akashi,Victoria L. Cammann,Filippo Crea,Leonarda Galiuto,Walter Desmet,Tetsuro Yoshida,Roberto Manfredini,Ingo Eitel,Masami Kosuge,Holger Nef,Abhishek Deshmukh,Amir Lerman,Eduardo Bossone,Rodolfo Citro,Takashi Ueyama,Domenico Corrado,Satoshi Kurisu,Frank Ruschitzka,David E. Winchester,Alexander R. Lyon,Elmir Omerovic,Jeroen J. Bax,Patrick Meimoun,G. Tarantini,Charanjit S. Rihal,Shams Y. Hassan,Federico Migliore,John D. Horowitz,Hiroaki Shimokawa,Thomas F. Lüscher,Christian Templin +35 more
TL;DR: The clinical expert consensus document part I summarizes the current state of knowledge on clinical presentation and characteristics of TTS and agrees on controversies surrounding TTS such as nomenclature, different TTS types, role of coronary artery disease, and etiology.
Journal ArticleDOI
Drug-Eluting Stent and Coronary Thrombosis: Biological Mechanisms and Clinical Implications
Thomas F. Lüscher,Jan Steffel,Franz R. Eberli,Michael Joner,Gaku Nakazawa,Felix C. Tanner,Renu Virmani +6 more
TL;DR: Evidence of a substantially higher risk of stent thrombosis in drug-eluting stents in DES remains inconclusive; as a consequence, both large-scale and long-term clinical trials are needed.